Drug class

Non-Steroidal Anti-Inflammatory (NSAID) and Salicylates

Nonsteroidal anti-inflammatory drugs and salicylates constitute a broad therapeutic class of non-opioid analgesic, antipyretic, and anti-inflammatory agents. Read more about Non-Steroidal Anti-Inflammatory (NSAID) and Salicylates

1,288 drugs in this class 318 manufacturers

Advertisement

Drugs in Non-Steroidal Anti-Inflammatory (NSAID) and Salicylates

Showing 937–945 of 1,288 drugs

NAPROXEN SODIUM

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES · TOOTHACHE ·+5
CHAIN DRUG

IBUPROFEN

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES · DYSMENORRHEA ·+6
STRIDES PHARMA

FLURBIPROFEN

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES · RHEUMATOID ARTHRITIS ·+1
LEHIGH VALLEY T

KETOROLAC TROMETHAMINE

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES · POST-OP PHOTOPHOBIA ·+3
CAPLIN STERILES

DICLOFENAC POTASSIUM

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES · DYSMENORRHEA ·+3
AUROBINDO PHARM

DICLOFENAC SODIUM

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES · OSTEOARTHRITIS OF THE KNEE ·+1
AUROBINDO PHARM
Filter & compare in the drug finder → Opens the drug finder with Non-Steroidal Anti-Inflammatory (NSAID) and Salicylates preselected. Add indication or manufacturer filters there.

About Non-Steroidal Anti-Inflammatory (NSAID) and Salicylates.

Nonsteroidal anti-inflammatory drugs and salicylates constitute a broad therapeutic class of non-opioid analgesic, antipyretic, and anti-inflammatory agents.

Although often grouped together in clinical formularies and drug-interaction labeling, salicylates represent a structural subclass within or closely related to traditional NSAIDs.

These agents primarily work by inhibiting cyclooxygenase enzymes, thereby decreasing the downstream biosynthesis of pro-inflammatory prostaglandins and thromboxanes.

They are widely indicated for managing mild-to-moderate acute pain, fever, and chronic inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, with select salicylates also serving key antiplatelet roles in cardiovascular disease prevention.